UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer

Nature (London), 2019-07, Vol.571 (7765), p.413-418

2019

Volltextzugriff (PDF)

The non-coding transcriptome as a dynamic regulator of cancer metastasis

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.1-16

2014

Volltextzugriff (PDF)

Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas

Science translational medicine, 2016-11, Vol.8 (366), p.366ra161

2016

Volltextzugriff (PDF)

Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112965-112965, Article 112965

2023

Volltextzugriff (PDF)

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

Oncotarget, 2014-02, Vol.5 (3), p.764-774

2014

Volltextzugriff (PDF)

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer

Scientific reports, 2017-06, Vol.7 (1), p.4079-10, Article 4079

2017

Volltextzugriff (PDF)

PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

Nature communications, 2024-06, Vol.15 (1), p.5487-15, Article 5487

2024

Volltextzugriff (PDF)

The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo

Molecular cancer, 2015-02, Vol.14 (1), p.46-46, Article 46

2015

Volltextzugriff (PDF)

The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program

Molecular oncology, 2019-05, Vol.13 (5), p.1121-1136

2019

Volltextzugriff (PDF)

Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression

Molecular oncology, 2016-05, Vol.10 (5), p.693-703

2016

Volltextzugriff (PDF)

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

Clinical epigenetics, 2016-02, Vol.8 (16), p.16-16, Article 16

2016

Volltextzugriff (PDF)

GENT-32. COMPREHENSIVE TRANSCRIPTOMIC ANALYSIS OF PEDIATRIC AND ADULT HUMAN BRAIN TUMORS FOR DISCOVERY OF BRAIN TUMOR-ASSOCIATED LONG NON-CODING RNAS

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi81-vi81

2016

Volltextzugriff (PDF)

Multivalent Proteins Rapidly and Reversibly Phase-Separate upon Osmotic Cell Volume Change

Molecular cell, 2020-09, Vol.79 (6), p.978-990.e5

2020

Volltextzugriff (PDF)

Non-invasive metabolic imaging of brain tumours in the era of precision medicine

Nature reviews. Clinical oncology, 2016-12, Vol.13 (12), p.725-739

2016

Volltextzugriff (PDF)

Abstract 4420: Polytect, a robust algorithm to detect somatic mutations in polymorphic MHC/HLA genes

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4420-4420

2020

Volltextzugriff (PDF)

Abstract 3347: Exploring the role of ASXL family of genes in enabling oncogenic AR-signaling in prostate cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3347-3347

2017

Volltextzugriff (PDF)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2

Proceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (1), p.1-12

2021

Volltextzugriff (PDF)

Competing for enhancers: PVT1 fine-tunes MYC expression

Cell research, 2018-08, Vol.28 (8), p.785-786

2018

Volltextzugriff (PDF)

Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader

Journal of medicinal chemistry, 2024-05, Vol.67 (9), p.6938-6951

2024

Volltextzugriff (PDF)

Abstract 4399: Exploring the postmitotic roles of STAG2 mutations in solid tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4399-4399

2019

Volltextzugriff (PDF)

Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (20), p.5731-5740

2018

Volltextzugriff (PDF)

Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas

Proceedings of the National Academy of Sciences - PNAS, 2023-05, Vol.120 (18), p.e2221175120-e2221175120

2023

Volltextzugriff (PDF)

Abstract 1945: Degradation of ERG transcription factor as a targeted therapy in B-cell and T-cell acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1945-1945

2018

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)
Tagungsberichte
(1)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(25)
Life Sciences & Biomedicine
(23)
Male
(15)
Prostate Cancer
(15)
Animals
(14)
Cell Line, Tumor
(11)
Mice
(11)
Oncology
(11)
Cell Biology
(8)
Gene Expression
(8)
Gene Expression Regulation, Neoplastic
(8)
Metastasis
(8)
Androgens
(7)
Cancer
(7)
Multidisciplinary Sciences
(7)
Prostatic Neoplasms - Genetics
(7)
Science & Technology - Other Topics
(7)
Androgen Receptors
(6)
Genetic Aspects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

The non-coding transcriptome as a dynamic regulator of cancer metastasis

Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas

Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer

PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo

The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program

The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms

Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

GENT-32. COMPREHENSIVE TRANSCRIPTOMIC ANALYSIS OF PEDIATRIC AND ADULT HUMAN BRAIN TUMORS FOR DISCOVERY OF BRAIN TUMOR-ASSOCIATED LONG NON-CODING RNAS

Multivalent Proteins Rapidly and Reversibly Phase-Separate upon Osmotic Cell Volume Change

Non-invasive metabolic imaging of brain tumours in the era of precision medicine

Abstract 4420: Polytect, a robust algorithm to detect somatic mutations in polymorphic MHC/HLA genes

Abstract 3347: Exploring the role of ASXL family of genes in enabling oncogenic AR-signaling in prostate cancer

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2

Competing for enhancers: PVT1 fine-tunes MYC expression

Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader

Abstract 4399: Exploring the postmitotic roles of STAG2 mutations in solid tumors

Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer

Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas

Abstract 1945: Degradation of ERG transcription factor as a targeted therapy in B-cell and T-cell acute lymphoblastic leukemia

Suchergebnisse filtern